Aug 31 (Reuters) - Simavita Ltd (SVA) FY consolidated revenue from ordinary activities $908,665, up 15 percent FY consolidated loss attributable to members of group $7.8 million
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025